Literature DB >> 30728660

Drug-Eluting Balloons and Drug-Eluting Stents in the Treatment of Peripheral Vascular Disease.

Jonathan Lindquist1, Kristofer Schramm1.   

Abstract

In the last 20 years, peripheral artery disease (PAD) has been increasingly recognized as a significant cause of morbidity and mortality in the United States. The endovascular treatment of PAD has seen a marked rise as minimally invasive techniques and devices have been refined. Two newer devices, drug-eluting stents and drug-eluting balloons, are on the forefront of the battle against limb loss from PAD. This review focuses on the data backing the use of drug-eluting technologies for use in the peripheral arterial system.

Entities:  

Keywords:  atherosclerosis; interventional radiology; paclitaxel; peripheral artery disease

Year:  2019        PMID: 30728660      PMCID: PMC6363541          DOI: 10.1055/s-0038-1676360

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  74 in total

1.  Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

Authors:  D J Adam; J D Beard; T Cleveland; J Bell; A W Bradbury; J F Forbes; F G R Fowkes; I Gillepsie; C V Ruckley; G Raab; H Storkey
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

2.  Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia.

Authors:  Maximiano Albers; Marcello Romiti; Francisco Cardoso Brochado-Neto; Nelson De Luccia; Carlos Alberto Bragança Pereira
Journal:  J Vasc Surg       Date:  2006-03       Impact factor: 4.268

3.  Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.

Authors:  Gunnar Tepe; Thomas Zeller; Thomas Albrecht; Stephan Heller; Uwe Schwarzwälder; Jean-Paul Beregi; Claus D Claussen; Anja Oldenburg; Bruno Scheller; Ulrich Speck
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

4.  Prevalence and clinical impact of stent fractures after femoropopliteal stenting.

Authors:  Dierk Scheinert; Susanne Scheinert; Jacqueline Sax; Christopher Piorkowski; Sven Bräunlich; Matthias Ulrich; Giancarlo Biamino; Andrej Schmidt
Journal:  J Am Coll Cardiol       Date:  2005-01-18       Impact factor: 24.094

5.  Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease.

Authors:  Krishna J Rocha-Singh; Michael R Jaff; Tami R Crabtree; Daniel A Bloch; Gary Ansel
Journal:  Catheter Cardiovasc Interv       Date:  2007-05-01       Impact factor: 2.692

6.  Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.

Authors:  Stephan H Duda; Marc Bosiers; Johannes Lammer; Dierk Scheinert; Thomas Zeller; Vincent Oliva; Alexander Tielbeek; John Anderson; Benjamin Wiesinger; Gunnar Tepe; Alexandra Lansky; Michael R Jaff; Catharina Mudde; Hans Tielemans; Jean-Paul Beregi
Journal:  J Endovasc Ther       Date:  2006-12       Impact factor: 3.487

7.  Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia.

Authors:  Marcello Romiti; Maximiano Albers; Francisco Cardoso Brochado-Neto; Anai Espinelli S Durazzo; Carlos Alberto Bragança Pereira; Nelson De Luccia
Journal:  J Vasc Surg       Date:  2008-04-18       Impact factor: 4.268

8.  Extracellular matrix changes in stented human coronary arteries.

Authors:  Andrew Farb; Frank D Kolodgie; Jin-Yong Hwang; Allen P Burke; Kirubel Tefera; Deena K Weber; Thomas N Wight; Renu Virmani
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

9.  Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.

Authors:  Bruno Scheller; Ulrich Speck; Claudia Abramjuk; Ulrich Bernhardt; Michael Böhm; Georg Nickenig
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

Review 10.  Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries.

Authors:  John R Laird
Journal:  J Endovasc Ther       Date:  2006-02       Impact factor: 3.487

View more
  4 in total

1.  Slow-flow phenomena following lower limb paclitaxel- and sirolimus-coated balloon angioplasty in the setting of chronic limb threatening ischaemia-a case series.

Authors:  Tjun Y Tang; Muhammad S B Sulaiman; Shereen X Y Soon; Charyl J Q Yap; Ankur Patel; Tze T Chong
Journal:  Quant Imaging Med Surg       Date:  2022-03

Review 2.  Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease?

Authors:  Mohamed M Gad; Antonette K Karrthik; Ahmad A Mahmoud; Ahmed N Mahmoud
Journal:  Curr Cardiol Rep       Date:  2019-09-07       Impact factor: 2.931

3.  A homogenized constrained mixture model of restenosis and vascular remodelling after balloon angioplasty.

Authors:  Lauranne Maes; An-Sofie Cloet; Inge Fourneau; Nele Famaey
Journal:  J R Soc Interface       Date:  2021-05-05       Impact factor: 4.118

Review 4.  Drug-Eluting Stents and Balloons-Materials, Structure Designs, and Coating Techniques: A Review.

Authors:  I Rykowska; I Nowak; R Nowak
Journal:  Molecules       Date:  2020-10-11       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.